Buchumschlag

Association between atopic dermatitis burden and sociodemographic index with dupilumab and tralokinumab utilization across 50 countries

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Arbie Sofia P. Merilleno, Mina Tadrous, Inna Ushcatz, Heather J. Zhao, Aaron M. Drucker
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	International Journal of Dermatology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Single‐centre experience with tralokinumab in dupilumab‐experienced and naïve patients with atopic dermatitis
von: Claire Fossati, et al.
Veröffentlicht: (2024)

Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real‐world comparative study
von: Tiago Torres, et al.
Veröffentlicht: (2025)

Evolution of dupilumab‐associated conjunctivitis in patients with atopic dermatitis after switching dupilumab to tralokinumab or Janus kinase inhibitors (RESO‐ADOC study)
von: Ziad Reguiai, et al.
Veröffentlicht: (2024)

Effectiveness of dupilumab in tralokinumab‐resistant patients with atopic dermatitis: A real‐world experience from two referral centres
von: Gianluca Tavoletti, et al.
Veröffentlicht: (2024)

Fears for tears? Targeted therapies for atopic dermatitis and ocular surface health
von: Carolyn Jack, et al.
Veröffentlicht: (2024)

Real‐world experience of switching from tralokinumab to lebrikizumab in atopic dermatitis
von: Teppei Hagino, et al.
Veröffentlicht: (2025)

Reply to ‘Real‐world experience of switching from tralokinumab to lebrikizumab in atopic dermatitis’
von: Fabrizio Martora, et al.
Veröffentlicht: (2025)

Effectiveness of dupilumab in pediatric patients with a nummular phenotype of atopic dermatitis
von: Eun Jae Kim, et al.
Veröffentlicht: (2024)

Erythema induratum of Bazin during successful treatment of atopic dermatitis with dupilumab
von: ChaoJing Zhou, et al.
Veröffentlicht: (2024)

Bridging the gap: Treatment of atopic dermatitis with dupilumab during pregnancy
von: Christian Vestergaard, et al.
Veröffentlicht: (2025)

Efficacy and safety of tralokinumab in the treatment of head and neck pattern atopic dermatitis: A multicentre study of 12 patients
von: Francisco José Navarro‐Triviño, et al.
Veröffentlicht: (2024)

Drug survival of abrocitinib compared to dupilumab in adult patients with atopic dermatitis
von: Qingjie Hu, et al.
Veröffentlicht: (2024)

Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity
von: Joséphine Dupuis, et al.
Veröffentlicht: (2024)

A case series of live attenuated vaccine administration in dupilumab‐treated children with atopic dermatitis
von: Elaine C. Siegfried, et al.
Veröffentlicht: (2024)

Detecting T‐cell receptor clonality in patients with severe atopic dermatitis refractory to dupilumab
von: Hyungdon Kook, et al.
Veröffentlicht: (2024)

Efficacy of abrocitinib and dupilumab in itch‐dominant atopic dermatitis: An analysis of 2 trials
von: Jonathan I. Silverberg, et al.
Veröffentlicht: (2026)

Pregnancy and breastfeeding outcome in patients with atopic dermatitis treated with dupilumab: the clinical experience of three centers
von: Joana Xará, et al.
Veröffentlicht: (2024)

Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate‐to‐severe atopic dermatitis: A nationwide retrospective cohort study
von: Gianluca Avallone, et al.
Veröffentlicht: (2024)

Residual facial erythema in atopic dermatitis patients treated with dupilumab stratified by machine learning
von: Koichi Ashizaki, et al.
Veröffentlicht: (2024)

Dose tapering of dupilumab in patients with persistently controlled atopic dermatitis: a Spanish multicenter cohort study
von: Miguel A. Lasheras‐Pérez, et al.
Veröffentlicht: (2024)

Clinical effectiveness of combined dupilumab and baricitinib in a patient with multi‐drug resistant severe atopic dermatitis
von: Anna Paola Lugli, et al.
Veröffentlicht: (2024)

Severe atopic dermatitis in an Asian‐Arabic population treated with dupilumab: A retrospective observational study
von: Radi Al Chalabi, et al.
Veröffentlicht: (2024)

Reassuring evidence on infection risk with dupilumab in atopic dermatitis: Lessons from real‐world evidence
von: Lian F. van der Gang, et al.
Veröffentlicht: (2025)

Effectiveness of dupilumab in the treatment of alopecia areata in patients with concurrent atopic dermatitis: a real‐life retrospective study
von: Gianluca Tavoletti, et al.
Veröffentlicht: (2024)

Interplay between diabetes mellitus and atopic dermatitis
von: Dongyun Lei, et al.
Veröffentlicht: (2024)

Patient and family burden in pediatric atopic dermatitis and its treatment pattern in Japan
von: Atsushi Otsuka, et al.
Veröffentlicht: (2024)

Possibility of maintaining remission with topical therapy alone after withdrawal of dupilumab in Japanese patients with atopic dermatitis and their characteristics in the real world
von: Ayu Watanabe, et al.
Veröffentlicht: (2024)

What is atopic dermatitis?
Veröffentlicht: (2025)

Long‐term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3‐year real‐life study
von: Alessandra Chiei‐Gallo, et al.
Veröffentlicht: (2024)

Switching from baricitinib to dupilumab as an advanced‐line treatment in pediatric patients with atopic dermatitis: a retrospective cohort study
von: Ayelet Ollech, et al.
Veröffentlicht: (2024)

Comment on ‘Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity’ by Dupuis et al.
von: Luca Potestio, et al.
Veröffentlicht: (2024)

Five‐year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real‐world study
von: Luigi Gargiulo, et al.
Veröffentlicht: (2025)

The real‐world, long‐term risk of infections associated with dupilumab in atopic dermatitis: A global cohort study
von: Khalaf Kridin, et al.
Veröffentlicht: (2025)

Bleach suit for atopic dermatitis
von: Manish K. Shah, et al.
Veröffentlicht: (2024)

Disease burden and treatment preference for moderate‐to‐severe atopic dermatitis in Taiwan: A discrete‐choice experiment
von: Yung‐Tsu Cho, et al.
Veröffentlicht: (2025)

International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi study
von: Anouk G. M. Caron, et al.
Veröffentlicht: (2024)

Association between atopic dermatitis and prurigo nodularis: a systematic review and meta‐analysis
von: Wei Li, et al.
Veröffentlicht: (2024)

The wide spectrum of disease burden in atopic dermatitis—Implications for more holistic approaches?
von: Alexander Salava
Veröffentlicht: (2024)

Multidisciplinary atopic dermatitis program: A novel approach to managing difficult‐to‐control atopic dermatitis patients
von: Alexis Tracy, et al.
Veröffentlicht: (2024)

Nemolizumab‐induced exacerbation of atopic dermatitis
von: Hirofumi Kamada, et al.
Veröffentlicht: (2024)